[go: up one dir, main page]

CN108619183A - The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica - Google Patents

The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica Download PDF

Info

Publication number
CN108619183A
CN108619183A CN201810564087.3A CN201810564087A CN108619183A CN 108619183 A CN108619183 A CN 108619183A CN 201810564087 A CN201810564087 A CN 201810564087A CN 108619183 A CN108619183 A CN 108619183A
Authority
CN
China
Prior art keywords
angelica dahurica
coumarin
compound
histamine
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810564087.3A
Other languages
Chinese (zh)
Inventor
贺怀贞
张涛
韩省力
卢闻
李维凤
贺浪冲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian Jiaotong University
Original Assignee
Xian Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian Jiaotong University filed Critical Xian Jiaotong University
Priority to CN201810564087.3A priority Critical patent/CN108619183A/en
Publication of CN108619183A publication Critical patent/CN108619183A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

一种白芷中香豆素类化合物的简单提取方法,通过甲醇对白芷进行提取,提取物主要含有欧前胡素,异欧前胡素等香豆素类化合物,并且测试了白芷提取物,欧前胡素,异欧前胡素及珊瑚菜素对由化合物48/80引起人肥大细胞KU812的组胺释放的拮抗作用。结果表明本提取制备工艺简单有效,且发现白芷提取物,欧前胡素,异欧前胡素及珊瑚菜素可以有效地拮抗由化合物48/80引起人肥大细胞KU812的组胺释放。本发明为研制新的抗过敏药物提供了新的方法和思路。A simple extraction method of coumarin compounds in Angelica dahurica, extracting Angelica dahurica with methanol, the extract mainly contains imperatorin, isoimperatorin and other coumarin compounds, and tested the extract of Angelica dahurica, Europe Antagonism of procuredin, isoimperatorin and aneurysin on histamine release from human mast cells KU812 induced by compound 48/80. The results show that the extraction and preparation process is simple and effective, and it is found that the extracts of Angelica dahurica, imperatorin, isoimperatorin and coralidin can effectively antagonize the release of histamine in human mast cells KU812 caused by compound 48/80. The invention provides a new method and idea for developing new antiallergic drugs.

Description

一种白芷中香豆素类化合物的简单提取方法及其应用A simple extraction method and application of coumarin compounds in Angelica dahurica

技术领域technical field

本发明属于医药技术领域,涉及一种白芷中香豆素类化合物的简单的提取方法及其应用。The invention belongs to the technical field of medicine, and relates to a simple extraction method and application of coumarin compounds in Angelica dahurica.

背景技术Background technique

白芷化学成分复杂,主要有香豆素类、生物碱类、挥发油、谷甾醇等,药理研究表明,白芷具有解热镇痛消炎作用,在心血管、中枢神经、平滑肌、抗肿瘤、光敏等方面有显著作用。香豆素的良好疗效使得香豆素提取方法的研究得到了很好的发展,但白芷中活性成分极性较近使得白芷中香豆素类物质的提取制备需要繁琐的步骤。The chemical composition of Angelica dahurica is complex, mainly including coumarins, alkaloids, volatile oil, sitosterol, etc. Pharmacological studies have shown that Angelica dahurica has antipyretic, analgesic and anti-inflammatory effects, and has important effects on cardiovascular, central nervous system, smooth muscle, anti-tumor, and photosensitivity. significant effect. The good curative effect of coumarin has made the research on the extraction method of coumarin has been well developed, but the polarity of the active ingredients in Angelica dahurica is relatively close, so the extraction and preparation of coumarin substances in Angelica dahurica need cumbersome steps.

药物类过敏反应是源于药物直接刺激肥大细胞或嗜碱性粒细胞,导致肥大细胞脱颗粒释放β-氨基己糖苷酶,组胺等活性递质而引发。在临床上,患者首次用药时即有可能发生类过敏反应,结果不仅给患者带来巨大的经济负担,也会造成新的痛苦甚至生命威胁。研究发现人源MrgprX2受体可介导类过敏反应,当药物刺激造MrgprX2受体后,可引起肥大细胞钙离子浓度升高而引发脱颗粒反应,进而导致类过敏反应发生。临床上所用的抗过敏药物主要是包括抗组胺类药物,过敏反应介质阻释剂及激素类药物。拮抗MrgprX2受体可以使得类过敏反应停滞在源头,但拮抗MrgprX2受体的抗过敏药物还是一片空白,因此MrgprX2受体拮抗剂的研究越来越受到人们的关注,药物拮抗MrgprX2受体的目的主要是使得从源头防止类过敏反应的发生,从根本上解决类过敏反应的危害,开发利用MrgprX2受体拮抗剂或先导化合物对抗过敏候选药物开发具有重要意义。Drug-like allergic reactions are caused by drugs directly stimulating mast cells or basophils, causing mast cells to degranulate and release β-hexosaminidase, histamine and other active transmitters. Clinically, anaphylactoid reactions may occur when patients take medicine for the first time, which not only brings huge economic burden to patients, but also causes new pain and even life-threatening. Studies have found that human MrgprX2 receptors can mediate anaphylactoid reactions. When MrgprX2 receptors are stimulated by drugs, the calcium ion concentration in mast cells can increase, triggering degranulation reactions, and then leading to anaphylactoid reactions. Clinically used antiallergic drugs mainly include antihistamine drugs, allergic reaction mediator release agents and hormone drugs. Antagonizing the MrgprX2 receptor can stop the hypersensitivity reaction at the source, but the antiallergic drugs that antagonize the MrgprX2 receptor are still blank. Therefore, the research on MrgprX2 receptor antagonists has attracted more and more attention. The purpose of drugs to antagonize the MrgprX2 receptor is mainly To prevent the occurrence of anaphylactoid reactions from the source and fundamentally solve the hazards of anaphylactoid reactions, it is of great significance to develop and utilize MrgprX2 receptor antagonists or lead compounds to develop antiallergic drug candidates.

发明内容Contents of the invention

本发明的目的在于提供一种白芷中香豆素类化合物的简单的提取方法及其应用。The purpose of the present invention is to provide a simple extraction method and application of coumarin compounds in Angelica dahurica.

为达到上述目的,本发明采用的技术方案为:In order to achieve the above object, the technical scheme adopted in the present invention is:

一种白芷中香豆素类化合物的简单提取方法,将白芷粗粉用甲醇超声,过滤后得提取液,除去甲醇,得香豆素类化合物。A simple method for extracting coumarin compounds from Angelica dahurica. The coarse powder of Angelica dahurica is ultrasonically filtered with methanol to obtain an extract, and the methanol is removed to obtain coumarin compounds.

本发明进一步的改进在于,超声的功率为200W,频率为40kHz,时间为30分钟。The further improvement of the present invention is that the power of the ultrasound is 200W, the frequency is 40kHz, and the time is 30 minutes.

本发明进一步的改进在于,白芷粗粉与甲醇的比为1g:3mL。The further improvement of the present invention is that the ratio of the coarse powder of Angelica dahurica to methanol is 1g:3mL.

一种基于上述方法提取的香豆素类化合物在制备抗过敏药物中的应用。An application of the coumarin compound extracted based on the above method in the preparation of antiallergic medicine.

本发明进一步的改进在于,抗过敏药物为用于拮抗MrgprX2受体的药物。A further improvement of the present invention is that the antiallergic drug is a drug for antagonizing MrgprX2 receptor.

本发明进一步的改进在于,抗过敏药物为用于抑制人肥大细胞KU812的组胺释放的药物。A further improvement of the present invention is that the antiallergic drug is a drug used to inhibit the release of histamine from human mast cells KU812.

本发明进一步的改进在于,抗过敏药物为临床可接受的药物制剂。A further improvement of the present invention is that the antiallergic drug is a clinically acceptable pharmaceutical preparation.

本发明进一步的改进在于,药物制剂是片剂、胶囊剂、颗粒剂或注射剂。A further improvement of the present invention lies in that the pharmaceutical preparation is tablet, capsule, granule or injection.

相对于现有技术,本发明的有益效果为:本发明采用甲醇对中药白芷进行超声提取,得到中香豆素类化合物,提取方法简单,并明确提出了香豆素类提取物抗类过敏反应的药理活性,发现了三种香豆素类化合物欧前胡素、异欧前胡素和珊瑚菜素具有抗类过敏反应的药理活性,能够用于制备具有抗过敏作用的药物。本发明运用体外细胞实验,用人肥大细胞模型KU812对应用本提取方法所得的香豆素类提取物及这三种香豆素类化合物抗过敏活性的作用进行了验证,发现应用本提取方法所得的香豆素类提取物及这三种香豆素类化合物均可以有效的拮抗由化合物48/80引起人肥大细胞KU812的组胺释放。说明应用本提取方法所得的白芷提取物及这三种呋喃香豆素类化合物能够用于制备具有抗过敏作用的药物。Compared with the prior art, the beneficial effects of the present invention are as follows: the present invention uses methanol to ultrasonically extract the traditional Chinese medicine Angelica dahurica to obtain coumarin compounds, the extraction method is simple, and it is clearly proposed that the coumarin extracts can resist anaphylaxis. The pharmacological activity of three coumarin compounds, imperatorin, isoimperatorin and coralidin, has been found to have anti-anaphylaxis pharmacological activity, and can be used to prepare drugs with anti-allergic effects. The present invention uses in vitro cell experiments to verify the anti-allergic activity of the coumarin extract obtained by this extraction method and the antiallergic activity of these three coumarin compounds with human mast cell model KU812, and finds that the extract obtained by this extraction method Both the coumarin extract and the three coumarin compounds can effectively antagonize the release of histamine from human mast cells KU812 induced by compound 48/80. It shows that the Angelica dahurica extract and these three furanocoumarin compounds obtained by applying the extraction method can be used to prepare medicines with antiallergic effects.

附图说明Description of drawings

图1为香豆素类提取物的HPLC色谱图。Fig. 1 is the HPLC chromatogram of coumarin extract.

图2为香豆素类提取物抑制由化合物48/80引起的KU812的组胺释放,以化合物48/80作为阳性对照药物,以TM缓冲液为阴性对照。Figure 2 shows that coumarin extract inhibits the release of histamine from KU812 caused by compound 48/80, compound 48/80 is used as a positive control drug, and TM buffer is used as a negative control.

图3为欧前胡素抑制由化合物48/80引起的KU812的组胺释放,以化合物48/80作为阳性对照药物,以TM缓冲液为阴性对照。Figure 3 shows that imperatorin inhibits the histamine release of KU812 caused by compound 48/80, compound 48/80 is used as a positive control drug, and TM buffer is used as a negative control.

图4为异欧前胡素抑制由化合物48/80引起的KU812的组胺释放,以化合物48/80作为阳性对照药物,以TM缓冲液为阴性对照。Figure 4 shows that isoimperatorin inhibits the release of histamine from KU812 caused by compound 48/80, compound 48/80 is used as a positive control drug, and TM buffer is used as a negative control.

图5为珊瑚菜素抑制由化合物48/80引起的KU812的组胺释放,以化合物48/80作为阳性对照药物,以TM缓冲液为阴性对照。Figure 5 shows that pectinoid inhibits the release of histamine from KU812 caused by compound 48/80, compound 48/80 is used as a positive control drug, and TM buffer is used as a negative control.

具体实施方式Detailed ways

下面结合附图以及具体实施例对本发明进行说明。The present invention will be described below in conjunction with the accompanying drawings and specific embodiments.

本发明通过甲醇对白芷进行提取,提取物主要含有欧前胡素,异欧前胡素等香豆素类化合物。并考察了白芷提取物,欧前胡素,异欧前胡素及珊瑚菜素对由化合物48/80引起人肥大细胞KU812的组胺释放的拮抗作用。研究结果表明本提取制备工艺简单有效,且发现白芷提取物,欧前胡素,异欧前胡素及珊瑚菜素可以有效地拮抗由化合物48/80引起人肥大细胞KU812的组胺释放。本发明为研制新的抗过敏药物提供了新的方法和思路。The invention extracts the Angelica dahurica with methanol, and the extract mainly contains coumarin compounds such as imperatorin and isoimperatorin. And investigated the antagonism of the extracts of Angelica dahurica, imperatorin, isoimperatorin and coralidin on the release of histamine from human mast cells KU812 induced by compound 48/80. The research results show that the extraction and preparation process is simple and effective, and it is found that the extracts of Angelica dahurica, imperatorin, isoimperatorin and coralidin can effectively antagonize the release of histamine in human mast cells KU812 caused by compound 48/80. The invention provides a new method and idea for developing new antiallergic drugs.

实施例1Example 1

1.实验方法1. Experimental method

将白芷饮片粉碎成粗粉,称白芷粗粉50g,置于具塞锥形瓶中,加入150mL甲醇,在超声的功率为200W,频率为40kHz的条件下超声提取30min。过滤得滤液,用旋转蒸发仪挥去溶剂(甲醇)即得香豆素提取物。此外,甲醇可以回收。The decoction slices of Angelica dahurica were crushed into coarse powder, and 50 g of Angelica dahurica coarse powder was weighed, placed in a stoppered Erlenmeyer flask, 150 mL of methanol was added, and ultrasonic extraction was performed for 30 minutes under the condition of ultrasonic power of 200 W and frequency of 40 kHz. The filtrate was filtered, and the solvent (methanol) was evaporated with a rotary evaporator to obtain the coumarin extract. Additionally, methanol can be recycled.

实施例2Example 2

1.实验方法1. Experimental method

(1)组胺释放(1) Histamine release

将KU812细胞接种于96孔板中30000个细胞/孔,培养过夜。96孔板经过1500rmp离心5min后,吸弃原培养基,分别加入90ul TM缓冲液(阴性对照组),药物的30ug/ml C48/80溶液(给药组)或30ug/ml C48/80溶液(阳性对照组)于培养箱37℃孵育30min,后1500rmp离心5min,各孔分别吸取50ul至ep管中。加入100ul氘代组胺乙腈溶液,后涡旋,12000×g离心10min,取上清,用HPLC-MS-MS测定组胺的含量。KU812 cells were seeded in 96-well plates at 30,000 cells/well and cultured overnight. After the 96-well plate was centrifuged at 1500rmp for 5min, the original culture medium was sucked out, and 90ul TM buffer (negative control group), 30ug/ml C48/80 solution of the drug (administration group) or 30ug/ml C48/80 solution (administration group) were added respectively. Positive control group) was incubated in an incubator at 37°C for 30 minutes, then centrifuged at 1500rmp for 5 minutes, and 50ul of each well was pipetted into ep tubes. Add 100ul of deuterated histamine acetonitrile solution, vortex, centrifuge at 12000×g for 10min, take the supernatant, and measure the content of histamine by HPLC-MS-MS.

2.实验结果2. Experimental results

数据用均数±标准误(mean±SEM)表示,图表绘制应用Graphpad Prism 5.0软件。The data are expressed as mean ± standard error (mean ± SEM), and the graphs are drawn using Graphpad Prism 5.0 software.

图1为香豆素类提取物的HPLC色谱图(1为欧前胡素,2为珊瑚菜素,3为异欧前胡素)。Fig. 1 is the HPLC chromatogram of coumarin extracts (1 is imperatorin, 2 is pectinoid, 3 is isoimperatorin).

图2为香豆素类提取物抑制由化合物48/80引起的KU812的组胺图(Control为阴性对照组,C48/80为阳性对照组,*P<0.05,**P<0.01,***P<0.001,n=4)。Fig. 2 is the histamine figure (Control is negative control group, C48/80 is positive control group, *P<0.05, **P<0.01, ** *P<0.001, n=4).

图3为欧前胡素抑制由化合物48/80引起的KU812的组胺图(Control为阴性对照组,C48/80为阳性对照组,*P<0.05,**P<0.01,***P<0.001,n=4)。Fig. 3 is the histamine graph of imperatorin inhibiting KU812 caused by compound 48/80 (Control is negative control group, C48/80 is positive control group, *P<0.05, **P<0.01, ***P <0.001, n=4).

图4为异欧前胡素抑制由化合物48/80引起的KU812的组胺释放图(Control为阴性对照组,C48/80为阳性对照组,*P<0.05,**P<0.01,***P<0.001,n=4)。Figure 4 is the histamine release graph of isoimperatorin inhibiting KU812 caused by compound 48/80 (Control is a negative control group, C48/80 is a positive control group, *P<0.05, **P<0.01, ** *P<0.001, n=4).

图5为珊瑚菜素抑制由化合物48/80引起的KU812的组胺释放图(Control为阴性对照组,C48/80为阳性对照组,*P<0.05,**P<0.01,***P<0.001,n=4)。Figure 5 is a map of the histamine release of pectinoids inhibiting KU812 caused by compound 48/80 (Control is a negative control group, C48/80 is a positive control group, *P<0.05, **P<0.01, ***P <0.001, n=4).

通过上述实验结果表明,本发明所述提取方法、方便、快捷,香豆素类化合物提取率高,对所得香豆素类提取物,及其主要成分欧前胡素,异欧前胡素和珊瑚菜素均能有效拮抗由化合物48/80引起的KU812的组胺释放,其中以欧前胡素和异欧前胡素为最佳。Show by above-mentioned experimental result, extraction method of the present invention, convenient, fast, coumarin compound extraction rate height, to gained coumarin class extract, and main component imperatorin thereof, isoimperatorin and All the corallins could effectively antagonize the histamine release of KU812 caused by compound 48/80, among which imperatorin and isoimperatorin were the best.

香豆素类化合物中主要成分欧前胡素,异欧前胡素和珊瑚菜素均具有拮抗由化合物48/80引起人肥大细胞KU812的组胺释放的作用以及拮抗由化合物48/80引起人肥大细胞KU812的组胺释放的作用。The main components of coumarin compounds, imperatorin, isoimperatorin and acarinin all have the effect of antagonizing the release of histamine from human mast cells KU812 induced by compound 48/80 and antagonizing the release of histamine from human mast cells KU812 induced by compound 48/80. Role of histamine release from mast cells KU812.

可见,本发明提取的香豆素类化合物,主要成分为欧前胡素、异欧前胡素和珊瑚菜素,该香豆素类化合物能够在制备抗过敏药物中的应用。该抗过敏药物为用于拮抗MrgprX2受体的药物或该抗过敏药物为用于抑制人肥大细胞KU812的组胺释放的药物。同时,该抗过敏药物为临床可接受的药物制剂,为片剂、胶囊剂、颗粒剂或注射剂。It can be seen that the main components of the coumarin compound extracted in the present invention are imperatorin, isoimperatorin and pectinoid, and the coumarin compound can be used in the preparation of antiallergic drugs. The antiallergic drug is a drug for antagonizing MrgprX2 receptors or the antiallergic drug is a drug for inhibiting the release of histamine from human mast cells KU812. Meanwhile, the antiallergic medicine is a clinically acceptable pharmaceutical preparation, which is tablet, capsule, granule or injection.

本发明发现了一种中药白芷中香豆素类化合物简单的提取方法,并明确提出了所得香豆素类提取物,及其主要成分欧前胡素,异欧前胡素和珊瑚菜素抗类过敏反应的药理活性,这是香豆素类化合物新的药理作用,即其具有良好的拮抗由化合物48/80引起的KU812的组胺释放作用,开拓了中药组分新的临床应用领域,对开发抗过敏药物具有重要意义。The present invention discovers a simple extraction method of coumarin compounds in the traditional Chinese medicine Angelica dahuricae, and clearly proposes the obtained coumarin extract, and its main components imperatorin, isoimperatorin and pectinoids. The pharmacological activity of anaphylaxis, which is a new pharmacological effect of coumarin compounds, that is, it has a good antagonism on the release of KU812 caused by compound 48/80, and has opened up a new field of clinical application of traditional Chinese medicine components. It is of great significance to the development of antiallergic drugs.

Claims (8)

1.一种白芷中香豆素类化合物的简单提取方法,其特征在于,将白芷粗粉用甲醇超声,过滤后得提取液,除去甲醇,得香豆素类化合物。1. a simple extraction method of coumarin compounds in Angelica dahurica, it is characterized in that, the Angelica dahurica coarse powder is ultrasonically obtained with methanol, after filtering, extracting solution is obtained, and methanol is removed to obtain coumarin compounds. 2.根据权利要求1所述的一种白芷中香豆素类化合物的简单提取方法,其特征在于,超声的功率为200W,频率为40kHz,时间为30分钟。2. the simple extraction method of coumarin compound in a kind of Angelica dahurica according to claim 1, is characterized in that, the power of ultrasonic is 200W, and frequency is 40kHz, and the time is 30 minutes. 3.根据权利要求1所述的一种白芷中香豆素类化合物的简单提取方法,其特征在于,白芷粗粉与甲醇的比为1g:3mL。3. the simple extraction method of the coumarin compound in a kind of Angelica dahurica according to claim 1, is characterized in that, the ratio of the coarse powder of Angelica dahurica and methanol is 1g: 3mL. 4.根据权利要求1-3任意一项所述的方法提取的香豆素类化合物在制备抗过敏药物中的应用。4. The application of the coumarin compounds extracted according to any one of the methods of claims 1-3 in the preparation of antiallergic drugs. 5.根据权利要求4所述的抗过敏药物为用于拮抗MrgprX2受体的药物。5. The antiallergic drug according to claim 4 is a drug for antagonizing the MrgprX2 receptor. 6.根据权利要求4所述的抗过敏药物为用于抑制人肥大细胞KU812的组胺释放的药物。6. The antiallergic drug according to claim 4 is a drug for inhibiting the release of histamine from human mast cells KU812. 7.根据权利要求4所述的抗过敏药物为临床可接受的药物制剂。7. the antiallergic drug according to claim 4 is a clinically acceptable pharmaceutical preparation. 8.根据权利要求7所述的药物制剂是片剂、胶囊剂、颗粒剂或注射剂。8. The pharmaceutical preparation according to claim 7 is tablet, capsule, granule or injection.
CN201810564087.3A 2018-06-04 2018-06-04 The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica Pending CN108619183A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810564087.3A CN108619183A (en) 2018-06-04 2018-06-04 The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810564087.3A CN108619183A (en) 2018-06-04 2018-06-04 The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica

Publications (1)

Publication Number Publication Date
CN108619183A true CN108619183A (en) 2018-10-09

Family

ID=63691378

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810564087.3A Pending CN108619183A (en) 2018-06-04 2018-06-04 The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica

Country Status (1)

Country Link
CN (1) CN108619183A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110251507A (en) * 2019-07-04 2019-09-20 西安交通大学 A drug application for asthma caused by substance P
CN110746436A (en) * 2019-11-14 2020-02-04 河南科技大学 A kind of extraction method of coumarin compounds in Angelica dahurica, and Angelica Root extract
CN114845709A (en) * 2019-11-05 2022-08-02 德米拉公司 MRGPRX2 antagonists for use in treating inflammatory disorders
CN117100790A (en) * 2023-10-11 2023-11-24 西安交通大学 Application of Corydalis Corydalis-Angelica Angelica Extract in Preparing Anti-Atopic Dermatitis Drugs
CN119745866A (en) * 2025-01-02 2025-04-04 郑州大学 New uses of imperatorin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058641A (en) * 2009-12-29 2011-05-18 成都中医药大学 Angelica dahurica extract and quality detection method
CN105061448A (en) * 2015-09-08 2015-11-18 聊城大学 Method for extracting, separating and purifying three kinds of coumarin from dahurian angelica root
CN107661328A (en) * 2017-11-15 2018-02-06 西安交通大学 Application of the furocoumarin compound in Claritin is prepared

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058641A (en) * 2009-12-29 2011-05-18 成都中医药大学 Angelica dahurica extract and quality detection method
CN105061448A (en) * 2015-09-08 2015-11-18 聊城大学 Method for extracting, separating and purifying three kinds of coumarin from dahurian angelica root
CN107661328A (en) * 2017-11-15 2018-02-06 西安交通大学 Application of the furocoumarin compound in Claritin is prepared

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
史洋等: "白芷中3个主要活性成分含量测定及其质量评价研究", 《中国中药杂志》 *
邱婧然等: "正交试验优选白芷中总香豆素的超声提取工艺 ", 《中国药房》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110251507A (en) * 2019-07-04 2019-09-20 西安交通大学 A drug application for asthma caused by substance P
CN114845709A (en) * 2019-11-05 2022-08-02 德米拉公司 MRGPRX2 antagonists for use in treating inflammatory disorders
CN110746436A (en) * 2019-11-14 2020-02-04 河南科技大学 A kind of extraction method of coumarin compounds in Angelica dahurica, and Angelica Root extract
CN117100790A (en) * 2023-10-11 2023-11-24 西安交通大学 Application of Corydalis Corydalis-Angelica Angelica Extract in Preparing Anti-Atopic Dermatitis Drugs
CN119745866A (en) * 2025-01-02 2025-04-04 郑州大学 New uses of imperatorin

Similar Documents

Publication Publication Date Title
CN108619183A (en) The simple extraction methods of coumarin kind compound and its application in a kind of root of Dahurain angelica
CN102846967B (en) A kind of pure component traditional Chinese medicine preparation for treating headache and its preparation process
CN114853712A (en) A kind of chromane type or chromene type heteroterpenoid compound and its extraction method and application
CN110483552B (en) A kind of monoterpene indole alkaloid compound and its preparation method and application
CN103304518B (en) Sesquiterpenoids and pharmaceutical composition thereof, and application of pharmaceutical composition in pharmacy
CN101040891B (en) Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids
CN103134882A (en) Assay method of metabolite of bergenin in animal body
CN116999424B (en) Acyl quinic acid compound and application thereof
CN106501389A (en) A kind of Essence of Intrinsic Change of Chinese Medicines Through Preparation research method
CN115260148B (en) Compound extracted and separated from long pepper and application of compound in preparation of anti-inflammatory drugs
CN107255691A (en) A kind of method that utilization LC-MS method detects Paeoniflorin interior metabolism product
CN116139154A (en) Application of cyclovirobuxine D in pharmacy
CN111228326A (en) A kind of preparation method and use of alkaloid compounds in licorice
CN111909228B (en) Alkaloid compound and preparation method and application thereof
CN103301134A (en) Pharmaceutical composition for treating hyperlipidemia as well as preparation method and applications
Wang et al. The key active ingredients identification and pharmacological mechanism investigation of extract of ethyl acetate from Er Miao San aganist rheumatoid arthritis
CN108030794A (en) Purposes of the Rhizoma Chuanxiong total alkaloid in the medicine for preparing treatment headache
CN103736105A (en) Novel study method of multi-component traditional Chinese medicine
CN116270628B (en) Pharmaceutical composition for preventing and treating Alzheimer disease and related diseases causing cognitive dysfunction
CN102631396B (en) Anti-lung cancer alstonia-leaf traditional Chinese herbal composite, method for preparing same and application thereof in preparing anti-lung cancer medicine
CN112279811A (en) C20Diterpenoid alkaloids, their preparation and use for treating pain related diseases
CN102850316B (en) Method for preparing Blumeatin
CN102399186B (en) Method for separating and purifying norisoboldine monomer
CN102070597A (en) Amide alkaloid and preparation method thereof
Ji et al. Research on the Extraction Technology of Alkaloids in natural medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181009

RJ01 Rejection of invention patent application after publication